ES498320A0 - Metodo de producir derivados de tiazolidina - Google Patents

Metodo de producir derivados de tiazolidina

Info

Publication number
ES498320A0
ES498320A0 ES498320A ES498320A ES498320A0 ES 498320 A0 ES498320 A0 ES 498320A0 ES 498320 A ES498320 A ES 498320A ES 498320 A ES498320 A ES 498320A ES 498320 A0 ES498320 A0 ES 498320A0
Authority
ES
Spain
Prior art keywords
thiazolidine derivatives
producing
producing thiazolidine
derivatives
thiazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES498320A
Other languages
English (en)
Spanish (es)
Other versions
ES8202546A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES8202546A1 publication Critical patent/ES8202546A1/es
Publication of ES498320A0 publication Critical patent/ES498320A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES498320A 1980-01-07 1981-01-05 Metodo de producir derivados de tiazolidina Granted ES498320A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP76280A JPS5697277A (en) 1980-01-07 1980-01-07 Thiazolidine derivative

Publications (2)

Publication Number Publication Date
ES8202546A1 ES8202546A1 (es) 1982-02-01
ES498320A0 true ES498320A0 (es) 1982-02-01

Family

ID=11482698

Family Applications (1)

Application Number Title Priority Date Filing Date
ES498320A Granted ES498320A0 (es) 1980-01-07 1981-01-05 Metodo de producir derivados de tiazolidina

Country Status (6)

Country Link
US (1) US4376777A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0032128A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5697277A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR228444A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK2281A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES498320A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
JPS58177983A (ja) * 1982-04-13 1983-10-18 Takeda Chem Ind Ltd チアゾリジン誘導体
WO1986002073A1 (en) * 1984-10-03 1986-04-10 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, process for their preparation, and pharmaceutical composition containing same
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5260445A (en) * 1987-09-04 1993-11-09 Beecham Group P.L.C. 2,4-thiazolidinediones
JPH01180102U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1988-06-02 1989-12-25
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
EP0526598B1 (en) * 1990-04-27 1996-12-18 Orion-Yhtymà„ Oy New pharmacologically active catechol derivatives
JPH0463570U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1990-10-09 1992-05-29
US5158966A (en) * 1991-02-22 1992-10-27 The University Of Colorado Foundation, Inc. Method of treating type i diabetes
JPH066904A (ja) * 1991-03-01 1994-01-14 Hitachi Kiden Kogyo Ltd クリーンルーム用無人搬送車の無人給電装置
EP0587377A3 (en) * 1992-09-10 1994-09-21 Lilly Co Eli Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
EP1006794B1 (en) * 1997-03-12 2007-11-28 Robert W. Esmond A method for treating or preventing alzheimer's disease
NZ501163A (en) 1997-06-18 2002-02-01 Smithkline Beecham P Treatment of diabetes with thiazolidinedione and sulphonylurea (glibenclamide, glipizide, gliclazide, glimepiride, tolazamide and tolbutamide
ID23372A (id) * 1997-06-18 2000-04-20 Smithkline Beecham Plc Pengobatan diabetes dengan tiazolidindion dan metformin
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
US7105552B2 (en) 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
AR023700A1 (es) * 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
TR200101333T2 (tr) * 1998-11-12 2001-10-22 Smithkline Beecham P.L.C. Bir ensülin sensitizörü ve başka bir anti-diyabetik maddenin değiştirilmiş salımı için farmasötik terkip.
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US7407978B2 (en) 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
JP2001072592A (ja) 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
WO2001002377A1 (en) * 1999-07-01 2001-01-11 Geron Corporation Telomerase inhibitors and methods of their use
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6958355B2 (en) * 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
AU2001294673A1 (en) * 2000-09-21 2002-04-02 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US20060047000A1 (en) * 2001-04-24 2006-03-02 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ES2296890T3 (es) * 2002-01-16 2008-05-01 General Electric Company Consola central de panel de instrumentos con cableado integrado.
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
AU2002339196A1 (en) * 2002-11-21 2004-06-15 Delavan Ltd Check valve
WO2005041951A2 (en) * 2003-10-28 2005-05-12 Rigel Pharmaceuticals, Inc. Rhodanine derivatives for use as antiviral agents
AR057324A1 (es) * 2005-05-27 2007-11-28 Wyeth Corp Tigeciclina y metodos para preparar 9-aminominociclina
ES2437149T3 (es) * 2008-02-22 2014-01-09 The Ohio State University Research Foundation Agentes supresores del receptor de andrógenos
EP2488027A4 (en) 2009-10-09 2013-04-17 Univ Ohio State Res Found THIAZOLIDINDIONENERGIERESTRIKTIONSMIMETIKA
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
US10034868B2 (en) 2014-11-04 2018-07-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1284516A (fr) * 1957-11-20 1962-02-16 France Etat Produits utilisables notamment comme agents susceptibles d'agir sur la croissance des plantes et leur procédé de fabrication
NL265085A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1960-05-24
US3200126A (en) * 1963-05-31 1965-08-10 Warner Lambert Pharmaceutical 3-alkyl-5-amino-2, 4-thiazolidinediones
US3825553A (en) * 1970-05-05 1974-07-23 Rorer Inc William H Certain 5-arylthiazolidines
SU480711A1 (ru) * 1973-07-02 1975-08-15 Ленинградский Ордена Трудового Красного Знамени Технологический Институт Им.Ленсовета Способ получени производных 3-оксиметилтиазолиндиона-2,4
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative

Also Published As

Publication number Publication date
DK2281A (da) 1981-07-08
US4376777A (en) 1983-03-15
EP0032128A1 (en) 1981-07-15
ES8202546A1 (es) 1982-02-01
AR228444A1 (es) 1983-03-15
JPS5697277A (en) 1981-08-05
JPS6310702B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-03-08

Similar Documents

Publication Publication Date Title
ES498320A0 (es) Metodo de producir derivados de tiazolidina
ES518800A0 (es) Un metodo de producir derivados de tiazolidina.
DOP1981004105A (es) Nuevos derivados de n-arilbenzamida
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL204549A1 (pl) Sposob wytwarzania pochodnych pirolidyny
PL209693A1 (pl) Sposob wytwarzania imidazolu
PL204550A1 (pl) Sposob wytwarzania pochodnych pirolidyny
ES508490A0 (es) "un metodo de produccion de derivados de tiazolidina".
PL211647A1 (pl) Sposob wytwarzania pochodnych imidazolu
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
ES502761A0 (es) Metodo de preparar nuevos derivados de taurina
PL204616A1 (pl) Sposob wytwarzania pochodnych 1-oksadetiacefamowych
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
DOP1981003010A (es) Nuevos derivados de isoxazolilimidazolidinona
KR850002010A (ko) 헤테로사이클릭 화합물의 제조방법
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
KR850002012A (ko) 헤테로 사이클릭 유도체의 제조방법
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
ES526647A0 (es) Metodo de preparar derivados de p-acilaminofenol
PL215005A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu